Brean Murray Carret & Co Maintains Hold Rating on Hologic

A report from Brean Murray Carret & Co reiterates its Hold rating on Hologic HOLX. The report states, “we do not anticipate FQ4 earning sor F12 guidance to be materially below current views. We expect the early update on Tomo adoption, to be at least on track with management “expectations” and may represent some positive “surprise” given what we perceive as low expectations." HOLX closed yesterday at $16.36.